Cardiovascular and metabolic responses to fasting and thermoneutrality are conserved in obese Zucker rats.
The primary purpose of the study was to test the hypothesis that reduced leptin signaling is necessary to elicit the cardiovascular and metabolic responses to fasting. Lean (Fa/?; normal leptin receptor; n = 7) and obese (fa/fa; mutated leptin receptor; n = 8) Zucker rats were instrumented with telemetry transmitters and housed in metabolic chambers at 23 degrees C (12:12-h light-dark cycle) for continuous (24 h) measurement of metabolic and cardiovascular variables. Before fasting, mean arterial pressure (MAP) was higher (MAP: obese = 103 +/- 3; lean = 94 +/- 1 mmHg), whereas oxygen consumption (VO(2): obese = 16.5 +/- 0.3; lean = 18.6 +/- 0.2 ml. min(-1). kg(-0.75)) was lower in obese Zucker rats compared with their lean controls. Two days of fasting had no effect on MAP in either lean or obese Zucker rats, whereas VO(2) (obese = -3.1 +/- 0.3; lean = -2.9 +/- 0.1 ml. min(-1). kg(-0.75)) and heart rate (HR: obese = -56 +/- 4; lean = -42 +/- 4 beats/min) were decreased markedly in both groups. Fasting increased HR variability both in lean (+1.8 +/- 0.4 ms) and obese (+2.6 +/- 0.3 ms) Zucker rats. After a 6-day period of ad libitum refeeding, when all parameters had returned to near baseline levels, the cardiovascular and metabolic responses to 2 days of thermoneutrality (ambient temperature 29 degrees C) were determined. Thermoneutrality reduced VO(2) (obese = -2.4 +/- 0.2; lean = -3.3 +/- 0.2 ml. min(-1). kg(-0.75)), HR (obese = -46 +/- 5; lean = -55 +/- 4 beats/min), and MAP (obese = -13 +/- 6; lean = -10 +/- 1 mmHg) similarly in lean and obese Zucker rats. The results indicate that the cardiovascular and metabolic responses to fasting and thermoneutrality are conserved in Zucker rats and suggest that intact leptin signaling may not be requisite for the metabolic and cardiovascular responses to reduced energy intake.
Overton
J M
JM
Departments of Nutrition, Food and Exercise Sciences and Program in Neuroscience, 236 Biomedical Research Facility, Florida State University, Tallahassee, FL 32306-4340, USA. moverton@mailer.fsu.edu
Williams
T D
TD
Chambers
J B
JB
Rashotte
M E
ME
D000818:Animals; D001794:Blood Pressure; D001833:Body Temperature Regulation / Q000502:physiology*; D002153:Calorimetry, Indirect; D002352:Carrier Proteins / Q000235:genetics / Q000502:physiology*; D002940:Circadian Rhythm; D004327:Drinking Behavior; D002149:Energy Intake; D005215:Fasting / Q000502:physiology*; D005247:Feeding Behavior; D006339:Heart Rate; D006439:Hemodynamics / Q000235:genetics / Q000502:physiology*; D008297:Male; D009043:Motor Activity; D009765:Obesity / Q000235:genetics / Q000503:physiopathology*; D010101:Oxygen Consumption; D051381:Rats; D011924:Rats, Zucker; D011956:Receptors, Cell Surface; D054411:Receptors, Leptin; D015656:Respiratory Mechanics; D013686:Telemetry; D013696:Temperature; D013851:Thinness
D002352:Carrier Proteins; D011956:Receptors, Cell Surface; D054411:Receptors, Leptin